Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T23:16:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-02-17T19:41:49.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T17:10:51.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.6%
    Check dated 2025-02-03T12:00:03.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.6%
    Check dated 2025-01-20T04:25:28.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.7%
    Check dated 2025-01-12T23:44:38.000Z thumbnail image

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.